Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nanobiotix (NBTX) Non-Current Assets (2018 - 2025)

Nanobiotix has reported Non-Current Assets over the past 8 years, most recently at $5.8 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 8.29% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $5.8 million, down 8.29%, while the annual FY2025 figure was $5.8 million, 8.29% down from the prior year.
  • Non-Current Assets for Q4 2025 was $5.8 million at Nanobiotix, down from $6.0 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $10.0 million in Q4 2021 and troughed at $5.8 million in Q4 2025.
  • A 5-year average of $7.5 million and a median of $7.2 million in 2023 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: dropped 4.85% in 2021 and later decreased 24.1% in 2022.
  • Year by year, Non-Current Assets stood at $10.0 million in 2021, then decreased by 24.1% to $7.6 million in 2022, then dropped by 6.69% to $7.1 million in 2023, then decreased by 9.88% to $6.4 million in 2024, then dropped by 8.29% to $5.8 million in 2025.
  • Business Quant data shows Non-Current Assets for NBTX at $5.8 million in Q4 2025, $6.0 million in Q2 2025, and $6.4 million in Q4 2024.